Exclusive: Myriad Genetics Discusses The Growing Market In Genetic Testing

By: via Benzinga
Myriad Genetics, Inc. (NASDAQ: MYGN) is a molecular diagnostic company engaged in the development and marketing of transformative ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.